Acknowledgements
The database was developed under the auspices of the International Consortium for Innovation and Quality in Pharmaceutical Development (IQ), a not-for-profit organization of pharmaceutical and biotechnology companies with a mission of advancing science and technology to augment the capability of member companies to develop transformational solutions that benefit patients, regulators and the broader research and development community. DruSafe is a Leadership Group of the IQ Consortium with the mission to advance nonclinical safety sciences and impact the global regulatory environment. We would like to thank the following biopharmaceutical companies and their scientists that contributed to the IQ Consortium database design and/or data collection: Abbvie (Sherry Ralston), AstraZeneca, Amgen (Katsu Ishida), Boehringer Ingelheim (Florian Colbatzky), Bristol Meyers Squibb, Eisai, Eli Lilly, Gilead (Carrie McMahon), GlaxoSmithKline, Janssen (Manisha Sonee), Merck (Danuta Herzyk), Novartis (Li Li), Pfizer, and UCB. Also, thanks to James Vergis for managing the database at the IQ Consortium.